Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 09:30AM ET
1.27
Dollar change
+0.02
Percentage change
2.00
%
Index- P/E- EPS (ttm)-0.29 Insider Own1.71% Shs Outstand11.53M Perf Week1.19%
Market Cap14.71M Forward P/E- EPS next Y- Insider Trans2.76% Shs Float11.34M Perf Month-15.00%
Income-3.32M PEG- EPS next Q- Inst Own29.31% Short Float0.19% Perf Quarter-28.77%
Sales1.60M P/S9.19 EPS this Y- Inst Trans-1.87% Short Ratio1.26 Perf Half Y-35.61%
Book/sh2.35 P/B0.54 EPS next Y- ROA-8.81% Short Interest0.02M Perf Year-42.05%
Cash/sh0.44 P/C2.91 EPS next 5Y- ROE-14.39% 52W Range1.15 - 2.75 Perf YTD-43.33%
Dividend Est.- P/FCF- EPS past 5Y49.33% ROI-10.09% 52W High-53.64% Beta1.12
Dividend TTM- Quick Ratio1.64 Sales past 5Y532.80% Gross Margin34.46% 52W Low10.87% ATR (14)0.06
Dividend Ex-Date- Current Ratio1.64 EPS Y/Y TTM71.62% Oper. Margin-300.19% RSI (14)36.76 Volatility5.39% 5.93%
Employees1 Debt/Eq0.27 Sales Y/Y TTM- Profit Margin-207.77% Recom3.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.21 EPS Q/Q83.28% Payout- Rel Volume1.39 Prev Close1.25
Sales Surprise- EPS Surprise- Sales Q/Q1132.08% EarningsNov 12 AMC Avg Volume16.68K Price1.27
SMA20-4.57% SMA50-13.46% SMA200-30.18% Trades Volume1,156 Change2.00%
Date Action Analyst Rating Change Price Target Change
Aug-07-20Downgrade Jefferies Hold → Underperform
May-19-20Downgrade JP Morgan Overweight → Neutral
Dec-02-19Initiated Guggenheim Buy
Oct-17-19Initiated H.C. Wainwright Buy $7
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-12-24 04:32PM
04:05PM
Aug-12-24 05:26PM
04:05PM
Jun-28-24 11:52AM
08:53PM Loading…
May-10-24 08:53PM
04:43PM
04:05PM
Mar-29-24 04:00PM
Mar-12-24 11:40AM
Jan-30-24 11:20PM
Nov-15-23 05:08AM
Nov-14-23 04:05PM
Aug-14-23 07:52AM
06:50AM
05:56PM Loading…
May-15-23 05:56PM
04:05PM
Apr-14-23 12:00PM
Apr-07-23 04:01PM
Jan-03-23 06:50AM
Dec-08-22 10:42AM
Dec-04-22 06:00PM
Nov-14-22 07:55PM
04:05PM
Oct-31-22 06:50AM
Oct-03-22 01:45PM
06:50AM
Sep-12-22 06:50AM
Aug-15-22 01:00PM
08:05AM
06:50AM Loading…
06:50AM
Aug-08-22 06:50AM
Aug-01-22 01:00PM
06:50AM
Jul-15-22 01:34PM
Jul-13-22 09:48AM
08:25AM
06:50AM
Jul-06-22 06:09AM
Jun-06-22 04:05PM
May-31-22 06:00AM
May-20-22 10:52AM
09:43AM
May-16-22 08:00PM
05:45PM
04:05PM
May-12-22 05:25PM
May-10-22 04:05PM
Apr-14-22 04:15PM
Mar-10-22 01:30PM
08:05AM
06:50AM
Mar-07-22 12:57PM
07:40AM
Mar-01-22 04:30PM
Feb-28-22 05:35PM
Feb-24-22 09:05AM
Jan-25-22 08:52AM
Jan-06-22 07:29AM
Jan-04-22 06:20AM
Dec-28-21 09:53AM
Dec-13-21 06:08AM
Dec-10-21 04:30PM
Dec-08-21 06:50AM
Nov-24-21 07:54AM
Nov-22-21 10:40AM
Nov-12-21 03:00AM
Nov-11-21 06:50AM
06:45AM
Nov-04-21 03:01PM
Oct-27-21 05:00PM
Oct-15-21 05:33PM
Oct-05-21 01:28PM
Oct-04-21 09:20AM
Sep-02-21 06:50AM
Aug-23-21 06:50AM
Aug-19-21 08:01AM
Aug-09-21 04:30PM
Aug-04-21 08:05AM
06:50AM
Jul-28-21 03:03PM
Jul-26-21 06:50AM
Jul-06-21 11:49AM
Jun-29-21 08:58AM
May-25-21 06:50AM
May-24-21 07:00AM
May-07-21 01:31AM
May-06-21 10:56AM
08:20AM
07:00AM
06:45AM
May-03-21 07:00AM
Apr-29-21 10:34AM
07:00AM
Apr-28-21 12:34PM
Apr-09-21 11:16AM
05:05AM
Apr-08-21 04:05PM
Mar-15-21 10:32AM
Mar-02-21 07:00PM
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Collins Cooper C.DirectorAug 22 '24Buy1.734,0947,09952,016Aug 26 05:40 PM
Collins Cooper C.DirectorAug 21 '24Buy1.701,2002,03947,922Aug 23 06:18 PM